简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-12-23 15:14 Newly published trial results showed spesolimab significantly improved signs and symptoms of flare in rare, life-threatening skin disease, generalized pustular psoriasis
2021-12-23 14:22 Xlear Files Legal Response to Government’s Lawsuit
2021-12-23 11:25 ViiV Healthcare announces US FDA approval of Apretude (cabotegravir extended-release injectable suspension), the first and only long-acting injectable option for HIV prevention
2021-12-22 14:00 Takeda Receives Complete Response Letter from the U.S. FDA for TAK-721
2021-12-22 09:20 Covetrus Announces New Structure, Focus and Strength within Europe
2021-12-21 14:22 Vifor Pharma reports positive outcome of the phase-IIIb DIAMOND trial of Veltassa®
2021-12-21 09:46 Merck Expands Neuroinflammatory Pipeline with Acquisition of Chord Therapeutics
2021-12-20 14:25 Vifor Pharma and American Regent announce settlement of Injectafer® patent litigation
2021-12-20 09:42 Prestige BioPharma Commences Construction of Innovative Discovery Center (IDC) in Busan, Korea
2021-12-20 08:57 TEPMETKO® (tepotinib) Receives Positive CHMP Opinion for Patients with Advanced NSCLC with METex14 Skipping Alterations
2021-12-17 19:07 Personalis Launches NeXT Personal™, A Tumor-Informed Liquid Biopsy Assay for MRD and Recurrence Detection With Part-Per-Million Sensitivity
2021-12-17 11:29 Boyd Corporation Acquires MBK Tape Solutions, Expands Biosensor, Transdermal Patch, and Medical Wearable Expertise
2021-12-17 09:31 Navient Neuro-navigation System Receives Chinese Regulatory Clearance
2021-12-16 16:25 Microba Life Sciences Becomes First Australian Microbiome Company Granted ISO15189 Accreditation by NATA
2021-12-16 14:40 Vifor Pharma drives transformation with divestment of non-core finished drug manufacturing to CordenPharma
2021-12-15 16:32 PCI Pharma Services Announces the Closing of Its Acquisition of LSNE
2021-12-15 14:26 Retrace AV Launches New Paint Product That Destroys SARS-CoV-2, the COVID-19 Virus Within 30 Minutes
2021-12-15 10:24 Organon Completes Acquisition of Forendo Pharma
2021-12-15 09:29 BostonGene and NEC Announce Global Partnership
2021-12-14 16:25 New Study Suggests That Masimo SedLine® Brain Function Monitoring May Aid Early Identification of Patients at Risk of Developing Postoperative Delirium

Business Wire Weibo

Press Releases

Latest Releases